SEC Form 4 · accession 0001144204-18-060328
Harvard Apparatus Regenerative Technology, Inc. · HRGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jing Chen
Director
Period of report
Nov 13, 2018
Accepted (ET)
Nov 15, 2018 · 7:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001563665
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.75 | Nov 13, 2018 | A | 10,897 | A | — | Nov 13, 2028 | Common Stock, par value $0.01 per share | 10,897 | 10,897 | D |
Explanation of responses
- F1The Stock Option shares will vest in four equal installments on February 13, 2019, May 13, 2019, August 13, 2019, and November 13, 2019.
Remarks
This form has been signed under power of attorney.